These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2384851)

  • 1. Prediction of glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z; Awazu S
    J Pharmacobiodyn; 1990 Feb; 13(2):142-57. PubMed ID: 2384851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z; Awazu S
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):212-8. PubMed ID: 2337943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of glycyrrhizin in the perfused liver of rats.
    Ishida S; Sakiya Y; Taira Z
    Biol Pharm Bull; 1994 Jul; 17(7):960-9. PubMed ID: 8000386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent pharmacokinetics of glycyrrhizin in rats.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1917-20. PubMed ID: 1394714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats.
    Ishida S; Sakiya Y; Ichikawa T; Awazu S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2509-13. PubMed ID: 2605701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of glycyrrhizin after intravenous administration to rats.
    Tsai TH; Liao JF; Shum AY; Chen CF
    J Pharm Sci; 1992 Sep; 81(9):961-3. PubMed ID: 1432649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.
    Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    Biol Pharm Bull; 1995 Feb; 18(2):337-41. PubMed ID: 7742809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Aikawa T; Osuga T; Iga T
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of glycyrrhizin by isolated rat hepatocytes.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z
    Biol Pharm Bull; 1993 Mar; 16(3):293-7. PubMed ID: 8364475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
    Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease.
    Wang Z; Okamoto M; Kurosaki Y; Nakayama T; Kimura T
    Biol Pharm Bull; 1996 Jun; 19(6):901-4. PubMed ID: 8799498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats.
    Ichikawa T; Ishida S; Sakiya Y; Sawada Y; Hanano M
    J Pharm Sci; 1986 Jul; 75(7):672-5. PubMed ID: 3761168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
    Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
    Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):577-93. PubMed ID: 6678311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of gastrointestinal absorption of glycyrrhizin in rats.
    Wang Z; Kurosaki Y; Nakayama T; Kimura T
    Biol Pharm Bull; 1994 Oct; 17(10):1399-403. PubMed ID: 7874064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of glycyrrhizin to human serum and human serum albumin.
    Ishida S; Sakiya Y; Ichikawa T; Kinoshita M; Awazu S
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):226-8. PubMed ID: 2720854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition.
    Tsuji H; Osaka S; Kiwada H
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1004-8. PubMed ID: 1893485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between pharmacokinetic behaviour of glycyrrhizin and hepatic function in patients with acute hepatitis and liver cirrhosis.
    Yamamura Y; Tanaka N; Santa T; Kotaki H; Aikawa T; Uchino K; Osuga T; Sawada Y; Iga T
    Biopharm Drug Dispos; 1995 Jan; 16(1):13-21. PubMed ID: 7711280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats.
    Shibayama Y
    Exp Mol Pathol; 1989 Aug; 51(1):48-55. PubMed ID: 2767217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.